TRIM28 is an E3 ligase for ARF-mediated NPM1/B23 SUMOylation that represses centrosome amplification

Molecular and Cellular Biology

Volumn 35, Issue 16, 2015, Pages 2851-2863

  Neo, Shu Hui ^a   Itahana, Yoko ^a   Alagu, Jennifer ^a   Kitagawa, Mayumi ^a   Guo, Alvin Kunyao ^a   Lee, Sang Hyun ^a   Tang, Kai ^b   Itahana, Koji ^a  

^a DUKE NUS MEDICAL SCHOOL   (Singapore)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

B23 PROTEIN; BINDING PROTEIN; NUCLEOPHOSMIN; TRIM28 PROTEIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR; NUCLEAR PROTEIN; REPRESSOR PROTEIN; TRIM28 PROTEIN, HUMAN; UBIQUITIN PROTEIN LIGASE;

ARTICLE; CELL EXPANSION; CENTROSOME; CONTROLLED STUDY; GENE OVEREXPRESSION; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; NUCLEOLUS; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SUMOYLATION; 3T3 CELL LINE; ANIMAL; CHEMISTRY; METABOLISM; MOUSE; PROTEIN PROTEIN INTERACTION; TUMOR CELL LINE; ULTRASTRUCTURE;

ADP-RIBOSYLATION FACTORS; ANIMALS; CELL LINE, TUMOR; CENTROSOME; HUMANS; MICE; NIH 3T3 CELLS; NUCLEAR PROTEINS; PROTEIN INTERACTION MAPS; REPRESSOR PROTEINS; SUMOYLATION; UBIQUITIN-PROTEIN LIGASES;

EID: 84937885093     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01064-14     Document Type: Article

References (46)

1. Palmero I, Pantoja C, Serrano M. 1998. p19ARF links the tumour suppressor p53 to Ras. Nature 395:125-126. http://dx.doi.org/10.1038/25870
2. Sherr CJ. 2006. Divorcing ARF and p53: an unsettled case. Nat Rev Cancer 6:663-673. http://dx.doi.org/10.1038/nrc1954
3. Weber JD, Jeffers JR, Rehg JE, Randle DH, Lozano G, Roussel MF, Sherr CJ, Zambetti GP. 2000. p53-independent functions of the p19ARF tumor suppressor. Genes Dev 14:2358-2365. http://dx.doi.org/10.1101/gad.827300
4. Xirodimas DP, Chisholm J, Desterro JMS, Lane DP, Hay RT. 2002. P14ARF promotes accumulation of SUMO-1 conjugated (H)Mdm2. FEBS Lett 528:207-211. http://dx.doi.org/10.1016/S0014-5793(02)03310-0
5. Tago K, Chiocca S, Sherr CJ. 2005. Sumoylation induced by the Arf tumor suppressor: a p53-independent function. Proc Natl Acad Sci U S A 102:7689-7694. http://dx.doi.org/10.1073/pnas.0502978102
6. Woods YL, Xirodimas DP, Prescott AR, Sparks A, Lane DP, Saville MK. 2004. p14 Arf promotes small ubiquitin-like modifier conjugation of Werners helicase. J Biol Chem 279:50157-50166. http://dx.doi.org/10.1074 /jbc.M405414200
7. Itahana K, Bhat KP, Jin A, Itahana Y, Hawke D, Kobayashi R, Zhang Y. 2003. Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation. Mol Cell 12:1151-1164. http://dx.doi.org/10.1016/S1097-2765(03)00431-3
8. Borer RA, Lehner CF, Eppenberger HM, Nigg EA. 1989. Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell 56:379-390. http://dx.doi.org/10.1016/0092-8674(89)90241-9
9. Liu X, Liu Z, Jang S-W, Ma Z, Shinmura K, Kang S, Dong S, Chen J, Fukasawa K, Ye K. 2007. Sumoylation of nucleophosmin/B23 regulates its subcellular localization, mediating cell proliferation and survival. Proc Natl Acad Sci U S A 104:9679-9684. http://dx.doi.org/10.1073 /pnas.0701806104
10. Grisendi S, Bernardi R, Rossi M, Cheng K, Khandker L, Manova K, Pandolfi PP. 2005. Role of nucleophosmin in embryonic development andtumorigenesis. Nature 437:147-153. http://dx.doi.org/10.1038/nature 03915
11. Ivanov AV, Peng H, Yurchenko V, Yap KL, Negorev DG, Schultz DC, Psulkowski E, Fredericks WJ, White DE, Maul GG, Sadofsky MJ, Zhou M-M, Rauscher FJ. 2007. PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing. Mol Cell 28:823-837. http://dx.doi.org/10.1016/j.molcel .2007.11.012
12. Liang Q, Deng H, Li X, Wu X, Tang Q, Chang TH, Peng H, Rauscher FJ, III, Ozato K, Zhu F. 2011. Tripartite motif-containing protein 28 is a small ubiquitin-related modifier E3 ligase and negative regulator of IFN regulatory factor 7. J Immunol 187:4754-4763. http://dx.doi.org/10.4049 /jimmunol.1101704
13. Yang Y, Fiskus W, Yong B, Atadja P, Takahashi Y, Pandita TK, Wang HG, Bhalla KN. 2013. Acetylated hsp70 and KAP1-mediated Vps34 SUMOylation is required for autophagosome creation in autophagy. Proc Natl Acad Sci U S A 110:6841-6846. http://dx.doi.org/10.1073/pnas .1217692110
14. Zhang Y, Xiong Y. 1999. Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53. Mol Cell 3:579-591. http://dx.doi.org/10.1016/S1097 -2765(00)80351-2
15. Zhang Y, Xiong Y, Yarbrough WG. 1998. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92:725-734. http://dx.doi.org /10.1016/S0092-8674(00)81401-4
16. Voorhoeve PM, Agami R. 2003. The tumor-suppressive functions of the human INK4A locus. Cancer Cell 4:311-319. http://dx.doi.org/10.1016 /S1535-6108(03)00223-X
17. Itahana K, Zhang Y. 2008. Mitochondrial p32 is a critical mediator of ARF-induced apoptosis. Cancer Cell 13:542-553. http://dx.doi.org/10 .1016/j.ccr.2008.04.002
18. Shinmura K, Tarapore P, Tokuyama Y, George KR, Fukasawa K. 2005. Characterization of centrosomal association of nucleophosmin/B23 linked to Crm1 activity. FEBS Lett 579:6621-6634. http://dx.doi.org/10 .1016/j.febslet.2005.10.057
19. Reboutier D, Troadec MB, Cremet JY, Fukasawa K, Prigent C. 2012. Nucleophosmin/B23 activates Aurora A at the centrosome through phosphorylation of serine 89. J Cell Biol 197:19-26. http://dx.doi.org/10.1083 /jcb.201107134
20. Weber JD, Kuo ML, Bothner B, DiGiammarino EL, Kriwacki RW, Roussel MF, Sherr CJ. 2000. Cooperative signals governing ARF-mdm2 interaction and nucleolar localization of the complex. Mol Cell Biol 20:2517-2528. http://dx.doi.org/10.1128/MCB.20.7.2517-2528.2000
21. Wang C, Ivanov A, Chen L, Fredericks WJ, Seto E, Rauscher FJ, III, Chen J. 2005. MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation. EMBO J 24:3279-3290. http://dx.doi.org/10 .1038/sj.emboj.7600791
22. Lee SB, Xuan Nguyen TL, Choi JW, Lee KH, Cho SW, Liu Z, Ye K, Bae SS, Ahn JY. 2008. Nuclear Akt interacts with B23/NPM and protects it from proteolytic cleavage, enhancing cell survival. Proc Natl Acad Sci U S A 105:16584-16589. http://dx.doi.org/10.1073/pnas.0807668105
23. Okuda M, Horn HF, Tarapore P, Tokuyama Y, Smulian AG, Chan PK, Knudsen ES, Hofmann IA, Snyder JD, Bove KE, Fukasawa K. 2000. Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication. Cell 103:127-140. http://dx.doi.org/10.1016/S0092-8674(00)00093-3
24. Kollman JM, Merdes A, Mourey L, Agard DA. 2011. Microtubule nucleation by -tubulin complexes. Nat Rev Mol Cell Biol 12:709-721. http://dx.doi.org/10.1038/nrm3209
25. Tokuyama Y, Horn HF, Kawamura K, Tarapore P, Fukasawa K. 2001. Specific phosphorylation of nucleophosmin on Thr(199) by cyclindependent kinase 2-cyclin E and its role in centrosome duplication. J Biol Chem 276:21529-21537. http://dx.doi.org/10.1074/jbc.M100014200
26. Zeng X, Shaikh FY, Harrison MK, Adon AM, Trimboli AJ, Carroll KA, Sharma N, Timmers C, Chodosh LA, Leone G, Saavedra HI. 2010. The Ras oncogene signals centrosome amplification in mammary epithelial cells through cyclin D1/Cdk4 and Nek2. Oncogene 29:5103-5112. http://dx.doi.org/10.1038/onc.2010.253
27. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. 1997. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88:593-602. http://dx.doi.org/10.1016 /S0092-8674(00)81902-9
28. Fukasawa K, Choi T, Kuriyama R, Rulong S, Vande Woude GF. 1996. Abnormal centrosome amplification in the absence of p53. Science 271:1744-1747. http://dx.doi.org/10.1126/science.271.5256.1744
29. Nakamura T, Saito H, Takekawa M. 2013. SAPK pathways and p53 cooperatively regulate PLK4 activity and centrosome integrity under stress. Nat Commun 4:1775. http://dx.doi.org/10.1038/ncomms2752
30. Shinmura K, Bennett RA, Tarapore P, Fukasawa K. 2007. Direct evidence for the role of centrosomally localized p53 in the regulation of centrosome duplication. Oncogene 26:2939-2944. http://dx.doi.org/10 .1038/sj.onc.1210085
31. Harvey M, Sands AT, Weiss RS, Hegi ME, Wiseman RW, Pantazis P, Giovanella BC, Tainsky MA, Bradley A, Donehower LA. 1993. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene 8:2457-2467.
32. Eymin B, Claverie P, Salon C, Leduc C, Col E, Brambilla E, Khochbin S, Gazzeri S. 2006. p14ARF activates a Tip60-dependent and p53- independent ATM/ATR/CHK pathway in response to genotoxic stress. Mol Cell Biol 26:4339-4350. http://dx.doi.org/10.1128/MCB.02240-05
33. di Tommaso A, Hagen J, Tompkins V, Muniz V, Dudakovic A, Kitzis A, Ladeveze V, Quelle DE. 2009. Residues in the alternative reading frame tumor suppressor that influence its stability and p53-independent activities. Exp Cell Res 315:1326-1335. http://dx.doi.org/10.1016/j.yexcr.2009 .01.010
34. Tompkins VS, Hagen J, Frazier AA, Lushnikova T, Fitzgerald MP, di Tommaso A, Ladeveze V, Domann FE, Eischen CM, Quelle DE. 2007. A novel nuclear interactor of ARF and MDM2 (NIAM) that maintains chromosomal stability. J Biol Chem 282:1322-1333. http://dx.doi.org/10 .1074/jbc.M609612200
35. Britigan EM, Wan J, Zasadil LM, Ryan SD, Weaver BA. 2014. The ARF tumor suppressor prevents chromosomal instability and ensures mitotic checkpoint fidelity through regulation of Aurora B. Mol Biol Cell 25:2761-2773. http://dx.doi.org/10.1091/mbc.E14-05-0966
36. Silk AD, Zasadil LM, Holland AJ, Vitre B, Cleveland DW, Weaver BA. 2013. Chromosome missegregation rate predicts whether aneuploidy will promote or suppress tumors. Proc Natl Acad SciUS A 110:E4134-E4141. http://dx.doi.org/10.1073/pnas.1317042110
37. Ganem NJ, Godinho SA, Pellman D. 2009. A mechanism linking extra centrosomes to chromosomal instability. Nature 460:278-282. http://dx .doi.org/10.1038/nature08136
38. Storchova Z, Pellman D. 2004. From polyploidy to aneuploidy, genome instability and cancer. Nat Rev Mol Cell Biol 5:45-54. http://dx.doi.org/10 .1038/nrm1276
39. Pihan GA, Purohit A, Wallace J, Knecht H, Woda B, Quesenberry P, Doxsey SJ. 1998. Centrosome defects and genetic instability in malignant tumors. Cancer Res 58:3974-3985.
40. Lingle WL, Barrett SL, Negron VC, D'Assoro AB, Boeneman K, Liu W, Whitehead CM, Reynolds C, Salisbury JL. 2002. Centrosome amplification drives chromosomal instability in breast tumor development. Proc Natl Acad Sci U S A 99:1978-1983. http://dx.doi.org/10.1073/pnas.032479999
41. Godinho SA, Picone R, Burute M, Dagher R, Su Y, Leung CT, Polyak K, Brugge JS, Thery M, Pellman D. 2014. Oncogene-like induction of cellular invasion from centrosome amplification. Nature 510:167-171. http://dx.doi.org/10.1038/nature13277
42. Meraldi P, Honda R, Nigg EA. 2002. Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53_/_ cells. EMBO J 21:483- 492. http://dx.doi.org/10.1093/emboj /21.4.483
43. Li L, Dutra A, Pak E, Labrie JE, III, Gerstein RM, Pandolfi PP, Recht LD, Ross AH. 2009. EGFRvIII expression and PTEN loss synergistically induce chromosomal instability and glial tumors. Neuro Oncol 11:9-21. http://dx.doi.org/10.1215/15228517-2008-081
44. Nam HJ, Chae S, Jang SH, Cho H, Lee JH. 2010. The PI3K-Akt mediates oncogenic Met-induced centrosome amplification and chromosome instability. Carcinogenesis 31:1531-1540. http://dx.doi.org/10.1093/carcin /bgq133
45. Bunz F, Fauth C, Speicher MR, Dutriaux A, Sedivy JM, Kinzler KW, Vogelstein B, Lengauer C. 2002. Targeted inactivation of p53 in human cells does not result in aneuploidy. Cancer Res 62:1129-1133.
46. Zhang X, Hagen J, Muniz VP, Smith T, Coombs GS, Eischen CM, Mackie DI, Roman DL, Van Rheeden R, Darbro B, Tompkins VS, Quelle DE. 2013. RABL6A,a novel RAB-like protein, controls centrosome amplification and chromosome instability in primary fibroblasts. PLoS One 8:e80228. http://dx.doi.org /10.1371/journal.pone.0080228